Five practice pointers for dispensing Paxlovid

Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.

Dealing with aggressive customers? You’re not alone

As confirmed cases of COVID-19 in Australia tick over 4,700, many pharmacists face long working hours and the rising challenge of unacceptable customer behaviour.

TGA approves Symbicort prn to treat mild asthma

Symbicort prn is now indicated to treat mild asthma flare-ups after an extended indication was approved by the TGA. Symbicort Turbuhaler and Rapihaler are now...

Small towns, big challenges

With the launch of a new PSA report, pharmacists in regional and remote areas highlight disadvantages that access to more funding, collaboration and medication management reviews could improve.

New PBS listing could change psoriasis treatment

Two additional targeted biologicals for severe chronic plaque psoriasis are now listed on the Pharmaceutical Benefits Scheme (PBS), offering relief for adults with the...

Pharmacy Future: Vision 2023

PSA has called for transformational change in the pharmacy profession within five years. So what could that future state look like? ‘By 2023, pharmacists within...